» Authors » Robert L Carithers Jr

Robert L Carithers Jr

Explore the profile of Robert L Carithers Jr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 953
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Carithers Jr R
Trans Am Clin Climatol Assoc . 2020 Jul; 131:270-285. PMID: 32675865
Since the first report of a successful liver transplant in 1968, access to this operation has dramatically improved. In 2018, 8,250 patients underwent liver transplantation in the United States. Despite...
2.
Louvet A, Thursz M, Kim D, Labreuche J, Atkinson S, Sidhu S, et al.
Gastroenterology . 2018 May; 155(2):458-468.e8. PMID: 29738698
Background & Aims: We performed a meta-analysis of individual patient data from 11 randomized controlled trials comparing corticosteroids, pentoxifylline, or their combination in patients with severe alcoholic hepatitis. We compared...
3.
Halldorson J, Carithers Jr R, Bhattacharya R, Bakthavatsalam R, Liou I, Dick A, et al.
World J Transplant . 2014 Oct; 4(3):206-15. PMID: 25346894
Aim: To hypothesize that the product of calculated Model for End-Stage Liver Disease score excluding exception points and donor age (D-MELD) risk capping ± Rule 14 could improve post liver...
4.
Baker E, Burnum-Johnson K, Jacobs J, Diamond D, Brown R, Ibrahim Y, et al.
Mol Cell Proteomics . 2014 Jan; 13(4):1119-27. PMID: 24403597
Rapid diagnosis of disease states using less invasive, safer, and more clinically acceptable approaches than presently employed is a crucial direction for the field of medicine. While MS-based proteomics approaches...
5.
Krishnan K, Bhattacharya R, Pereira A, Otto A, Carithers Jr R, Reyes J, et al.
Clin Transplant . 2013 Sep; 27(6):809-22. PMID: 23991828
Hospital length of stay (LOS) after liver transplantation has been determined to correlate with liver disease severity, post-transplant survival rates, and transplant-associated costs. A patient's model for end-stage liver disease...
6.
Diamond D, Krasnoselsky A, Burnum K, Monroe M, Webb-Robertson B, McDermott J, et al.
Hepatology . 2012 Feb; 56(1):28-38. PMID: 22331615
Unlabelled: Liver transplant tissues offer the unique opportunity to model the longitudinal protein abundance changes occurring during hepatitis C virus (HCV)-associated liver disease progression in vivo. In this study, our...
7.
Park E, Peccoud M, Wicks K, Halldorson J, Carithers Jr R, Reyes J, et al.
J Am Med Inform Assoc . 2010 Jul; 17(4):396-402. PMID: 20595306
Objective: Immunosuppressive therapy following transplantation, if not managed well, can lead to increased drug toxicity or rejection episodes. We investigated whether use of an automated clinical management system in our...
8.
Dick A, Spitzer A, Seifert C, Deckert A, Carithers Jr R, Reyes J, et al.
Liver Transpl . 2009 Jul; 15(8):968-77. PMID: 19642131
Controversies exist regarding the morbidity and mortality of patients undergoing liver transplantation at the extremes of the body mass index (BMI). A review of the United Network for Organ Sharing...
9.
Perkins J, Halldorson J, Bakthavatsalam R, Fix O, Carithers Jr R, Reyes J
Liver Transpl . 2009 Jan; 15(2):242-54. PMID: 19177441
Studies have shown that liver transplantation offers no survival benefits to patients with Model for End-Stage Liver Disease (MELD) scores <or= 14 in comparison with remaining on the waitlist. The...
10.
Ioannou G, Perkins J, Carithers Jr R
Gastroenterology . 2008 May; 134(5):1342-51. PMID: 18471511
Background & Aims: Since February 27, 2002, patients with early-stage hepatocellular carcinoma (HCC) have received priority for liver transplantation in the United States under the Model for End-Stage Liver Disease...